Clinical Trial Update: Immune Response to Hepatitis B Vaccine Challenge Dose in Subjects Who Received a Primary Neonatal Hepatitis B Vaccine. [Phase 4]

View source ↗

Summary

Phase 4 update evaluating the immune response to a hepatitis B vaccine challenge dose in individuals who previously received a neonatal hepatitis B vaccine. Spo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Engerix-B (hepatitis B vaccine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Hepatitis B | Phase 4 | Status: COMPLETED | Results posted: 2009-05-15